These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1877192)

  • 41. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
    Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C;
    J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Substitution therapy in immunologic deficiency syndromes].
    Iartsev MN; Gomes LA
    Pediatriia; 1989; (12):71-6. PubMed ID: 2628915
    [No Abstract]   [Full Text] [Related]  

  • 43. Modified immune globulin: its use in the prophylactic treatment of patients with immune deficiency.
    Ochs HD; Fischer SH; Wedgwood RJ
    J Clin Immunol; 1982 Apr; 2(2 Suppl):22S-30S. PubMed ID: 7045155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New immune globulin product.
    FDA Consum; 2006; 40(2):2. PubMed ID: 16671189
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent advances in the pathophysiology of primary immune deficiencies and immunoglobulin therapy in HIV infection and autoimmune/inflammatory neurological disorders. Symposium proceedings. Indian Wells, California, January 24-25, 1992.
    Pediatr Res; 1993 Jan; 33(1 Suppl):S1-100. PubMed ID: 8094549
    [No Abstract]   [Full Text] [Related]  

  • 46. IUIS/WHO notice. Appropriate uses of human immunoglobulin in clinical practice.
    Clin Exp Immunol; 1983 May; 52(2):417-22. PubMed ID: 6861378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous immunoglobulin therapy: indications, potential side effects, and treatment guidelines.
    Suez D
    J Intraven Nurs; 1995; 18(4):178-90. PubMed ID: 7629638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous immunoglobulin, immunodeficiency syndromes and idiopathic thrombocytopenic purpura. Proceedings of a workshop. Edinburgh, Scotland, 4 and 5 December 1986.
    J Infect; 1987 Jul; 15 Suppl 1():1-65. PubMed ID: 3117895
    [No Abstract]   [Full Text] [Related]  

  • 49. [Immunopathological bases and clinical considerations on the primary immunological deficiencies].
    Tridente G
    Recenti Prog Med; 1972 Jul; 53(1):1-64. PubMed ID: 4566149
    [No Abstract]   [Full Text] [Related]  

  • 50. Immune globulin therapy: new indications.
    Banks MA
    Nurs Spectr (Wash D C); 1998 Apr; 8(8):20-1. PubMed ID: 10542717
    [No Abstract]   [Full Text] [Related]  

  • 51. [Intravenous immunoglobulins in pediatric practice].
    Sharygin SL
    Pediatriia; 1991; (9):105-7. PubMed ID: 1754339
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of human immunoglobulins in premature infants.
    Stiehm ER
    Am J Pediatr Hematol Oncol; 1989; 11(2):235-7. PubMed ID: 2502038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Case of severe immunologic deficiency treated with transfer factor].
    Severi F; Ugazio AG; Colombo A
    Minerva Pediatr; 1974 Mar; 26(9):476-9. PubMed ID: 4840561
    [No Abstract]   [Full Text] [Related]  

  • 54. [Innovative production processes delivers immunoglobulin with very good clinical effectiveness].
    Krankenpfl J; 2005; 43(1-3):51. PubMed ID: 15912841
    [No Abstract]   [Full Text] [Related]  

  • 55. The assessment and management of primary antibody deficiency.
    Empson M; Sinclair J; O'Donnell J; Ameratunga R; Fitzharris P; Steele R;
    N Z Med J; 2004 Jun; 117(1195):U914. PubMed ID: 15282626
    [No Abstract]   [Full Text] [Related]  

  • 56. Complementary and alternative veterinary medicine: the immune system.
    Dodds WJ
    Clin Tech Small Anim Pract; 2002 Feb; 17(1):58-63. PubMed ID: 11890129
    [No Abstract]   [Full Text] [Related]  

  • 57. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Smart weapons.
    Kraco K
    Minn Med; 2004 May; 87(5):28-32. PubMed ID: 15191065
    [No Abstract]   [Full Text] [Related]  

  • 59. Intravenous immune globulin and the compromised host. Proceedings of a symposium, September 2l to 23, 1983, Dallas.
    Am J Med; 1984 Mar; 76(3A):1-231. PubMed ID: 6201066
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of chronic autoimmune thrombopenic purpura with intravenous immunoglobulins. Study of 18 cases].
    Janvier M; Clauvel JP; Tobelem G; Vainchenker W; Seligmann M; Boiron M
    Nouv Rev Fr Hematol (1978); 1983; 25(4):253-7. PubMed ID: 6684764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.